Zhenqiang Y. Zhang
No.156 Jinshui East Road
Zhengzhou, China
Zhengzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 103 publications
Rehmannioside D directly targets PTP1B to ameliorate metabolic dysfunction-associated fatty liver disease.
Journal: Journal of ethnopharmacology
Published: June 25, 2026
Liuwei Dihuang pills attenuates cognitive dysfunction in APP/PS1 mice through restoring mitochondrial homeostasis and activating the IRS/AKT/GSK3β insulin signaling pathway.
Journal: Frontiers in pharmacology
Published: May 08, 2026
Intranasal triptolide in mice: a strategy to reduce neuroinflammation and boost cognitive function.
Journal: Immunopharmacology and immunotoxicology
Published: December 29, 2025
Juyuanjian attenuates sarcopenia through dual regulation of the Akt/FoxO1 and SIRT1/PGC-1α pathways.
Juyuanjian attenuates sarcopenia through dual regulation of the Akt/FoxO1 and SIRT1/PGC-1α pathways.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: December 05, 2025
Kai-Xin-San alleviates Alzheimer's disease by targeting the DHFR-mediated folate-mitochondrial axis.
Kai-Xin-San alleviates Alzheimer's disease by targeting the DHFR-mediated folate-mitochondrial axis.
Journal: Journal of ethnopharmacology
Published: November 20, 2025
Mechanism of Atractylodis Rhizoma in improving cognitive dysfunction in Alzheimer's disease by regulating the cAMP/CREB/BDNF pathway.
Journal: International immunopharmacology
Published: August 28, 2025
Multi-target neuroprotection of Atractylodes macrocephala ethyl acetate extract against Alzheimer's disease: from bioactivity-guided screening to mechanistic validation.
Journal: Journal of ethnopharmacology
Published: July 10, 2025
Induced Pluripotent Stem Cells Derived Cellular Models for Investigating Parkinson's Disease Pathogenesis and Drug Screening.
Journal: Stem cell reviews and reports
Published: June 19, 2025
Discovery of Atractylenolide Derivatives as Novel LSD1 Inhibitors for the Treatment of Alzheimer's Disease.
Journal: Journal of agricultural and food chemistry
Published: June 05, 2025
Ferulic acid derived from Huanshaodan improves cognitive deficits in Alzheimer's disease model through regulating APP proteolytic processing via downregulation of SIRT2 expression.
Journal: Journal of ethnopharmacology
Published: June 03, 2025
Last Updated: 09/26/2026